Above the 40 (January 11, 2017) – A Market Soaring Back to the Edge of Overbought

AT40 = 69.0% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 63.3% of stocks are trading above their respective 200DMAs VIX = 9.9 Short-term Trading Call: cautiously bullish Commentary Last week, I complained about the stock market’s “rubber band” getting stretched. I claimed that AT40 (T2108), the percentage of stocks … Read more

Axovant Sciences: Betting On An Improved Risk Profile

I took immediate notice when Axovant Sciences (AXON) went public back in late 2015. The promise of a treatment for Alzheimer’s was a huge opportunity, and I immediately had thoughts of my grandfather who struggled with the disease for years before he passed away with a heart attack. Yet, AXON had no revenues and no … Read more

Above the 40 (July 26, 2017) – A Stock Market Floating Higher And Still On the Edge

AT40 = 63.6% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 60.3% of stocks are trading above their respective 200DMAs VIX = 9.6 (volatility index) Short-term Trading Call: cautiously bullish Commentary The stock market had a relatively bland day that matched a relatively bland statement on monetary policy from the … Read more

Above the 40 (July 6, 2017) – A Stock Market Swivel

AT40 = 48.1% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 55.4% of stocks are trading above their respective 200DMAs VIX = 12.5 (volatility index) Short-term Trading Call: neutral Commentary Diabolically, the stock market has put my head on the proverbial swivel. I earlier noted how the NASDAQ in particular … Read more